FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
about
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementiaThe genetics and neuropathology of frontotemporal lobar degenerationFUS-mediated regulation of alternative RNA processing in neurons: insights from global transcriptome analysisPhenotypic Heterogeneity of Monogenic Frontotemporal DementiaTherapeutic and diagnostic challenges for frontotemporal dementiaDiagnosis and management of behavioral variant frontotemporal dementiaFrontotemporal dementia and primary progressive aphasia, a reviewTau-targeted treatment strategies in Alzheimer's diseaseA loss of FUS/TLS function leads to impaired cellular proliferationFUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degenerationFrontotemporal dementia: a bridge between dementia and neuromuscular diseaseA 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degenerationFrontotemporal Dementia.Clinical characterization of bvFTD due to FUS neuropathology.Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia.Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLSBiomarkers in frontotemporal lobar degenerations--progress and challenges.Distinct pathological subtypes of FTLD-FUS.Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.Genetics of dementia.Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degenerationTau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.Functions of FUS/TLS from DNA repair to stress response: implications for ALS.Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches.An algorithm for genetic testing of frontotemporal lobar degenerationMultivesicular bodies in neurons: distribution, protein content, and trafficking functions.Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementiaHippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinicallyFamilial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathyFrontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathiesPsychotic symptoms in frontotemporal dementia: a diagnostic dilemma?ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutationsPathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutationClinico-pathological correlations of the most common neurodegenerative dementias.Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.
P2860
Q24600027-85CE899C-C4EF-49E8-A7FD-9C316D5E624EQ24615201-388E7B19-55DB-4CA2-8E3B-3CB5FEE1E478Q26773038-BBC2A872-B601-4A57-8D1F-D0CC06594530Q26782984-66BDD59D-3AEF-4E34-A0C0-DC11F26B032FQ26998919-1D7B630D-420B-47A7-8137-88A58A7A7E67Q27006258-0DD175FB-E69A-418D-B099-64D344F03E6EQ27021040-8D88EC86-EE0E-44ED-A7C7-B0883E007759Q27023429-EC50C1DD-0126-49E4-975F-2460B932FF78Q27331026-08FB3EE7-052B-48EA-96E9-4BBDA060FDFCQ27342067-91B5182F-AAB4-4ED5-AE57-7E143BE9B9ADQ28081198-683B8D18-CABE-4B9F-B419-03EC1CB7467EQ28488462-8D2C8E2E-9446-403D-96D6-6ADE44DC654CQ30234793-2056C415-34FC-487A-BD3B-40C20272E010Q30505752-24C823F0-6BEF-4DC8-8914-866908F94359Q30532680-3FE68C2E-EFD1-4E23-926D-E753F54F8B1CQ33698022-CC04412A-464D-4758-A8F9-660E1F70FBD3Q33889532-37DB028C-0602-4428-BC18-64638B4FF4AEQ33893515-78934094-0FE6-4738-96C1-C8D6F614A9DCQ34024578-90FB10E2-4EB4-4BC2-A931-4B6F28A1D4A7Q34028511-53991D60-9646-4955-93C8-1E48E7FAF27BQ34209561-FE1B65AF-A1A7-451E-9CD9-C316350AE7EBQ34248849-AE0E2DE4-4ED6-4301-8C99-4C2A49CC4473Q34254538-866D015F-0F9A-4FA9-9023-A9CB917E4AD4Q34256620-0C2F1AB3-F14C-4648-B7C8-1144B30BCAFEQ34263380-9CAD85C4-FE82-4CB4-A32D-A705D2DFBEFFQ34305789-039C33E6-4AD9-40A5-A4B9-E714D2441455Q34314477-A2BD496F-4268-4194-85F6-97FC60ADA1D6Q34555422-FDCEEA6B-835B-4FEC-AD44-9C0E47FE01BDQ34663489-1C92A551-7B4C-4D77-9787-B4E2F9B79E2FQ34746995-41C2A856-F1D6-4803-ABBC-73A4F1E3927EQ35022179-DBEB85D8-4BAB-44E3-8FE6-E01DA42B08E4Q35196395-5F061EDF-E4FD-436C-88AF-93409D590111Q35204586-9A62E58F-9E3B-475F-A0F2-8F36C44AD8C3Q35206942-734A608D-139C-4BE5-A789-210BF0DA5443Q35550855-5DDBF47D-487C-4583-A61E-BA305576E999Q35636403-40510033-F7B5-4A87-A0AD-3DC28BB73DBEQ35776901-2F61B99A-1879-43A3-9492-0F2F417EC806Q35869162-4D16B09A-1D8F-4D78-BDBE-39FC33837E05Q35923461-1D9F30C6-9A28-4839-9D9A-0B5665109ADEQ36003800-D7EEE820-CF9B-41EA-8E66-85B159A2ABF2
P2860
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FUS pathology defines the majo ...... totemporal lobar degeneration.
@ast
FUS pathology defines the majo ...... totemporal lobar degeneration.
@en
type
label
FUS pathology defines the majo ...... totemporal lobar degeneration.
@ast
FUS pathology defines the majo ...... totemporal lobar degeneration.
@en
prefLabel
FUS pathology defines the majo ...... totemporal lobar degeneration.
@ast
FUS pathology defines the majo ...... totemporal lobar degeneration.
@en
P2093
P2860
P50
P1476
FUS pathology defines the majo ...... totemporal lobar degeneration.
@en
P2093
Adrian M Isaacs
Astrid Authier
David M Mann
Eileen H Bigio
FReJA Consortium
Felix Geser
Gary Adamson
Harro Seelaar
Hazel Urwin
Ian R Mackenzie
P2860
P2888
P356
10.1007/S00401-010-0698-6
P50
P577
2010-05-20T00:00:00Z
P5875
P6179
1047182994